Adintrevimab

• CAT Number: I042183
• CAS Number: 2516243-54-0
• Purity: ≥95%

Adintrevimab（Cat No.:I042183）is a monoclonal antibody designed to target and neutralize the spike protein of the SARS-CoV-2 virus, which causes COVID-19. By binding to the spike protein, adintrevimab prevents the virus from entering human cells, thereby inhibiting infection. It is part of a class of monoclonal antibodies being developed as potential treatments for COVID-19, particularly in patients with mild to moderate disease who are at high risk of progression. Clinical trials are evaluating adintrevimab’s safety, efficacy, and potential to reduce the severity and duration of COVID-19 symptoms.